ZOVIA 1/35E-21 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zovia 1/35e-21, and when can generic versions of Zovia 1/35e-21 launch?
Zovia 1/35e-21 is a drug marketed by Watson Pharms Teva and is included in one NDA.
The generic ingredient in ZOVIA 1/35E-21 is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZOVIA 1/35E-21?
- What are the global sales for ZOVIA 1/35E-21?
- What is Average Wholesale Price for ZOVIA 1/35E-21?
Summary for ZOVIA 1/35E-21
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 48 |
| DailyMed Link: | ZOVIA 1/35E-21 at DailyMed |
US Patents and Regulatory Information for ZOVIA 1/35E-21
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Pharms Teva | ZOVIA 1/35E-21 | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-21 | 072720-001 | Dec 30, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
